Emergent Biosolutions (EBS) Surges 5.1%: Is This an Indication of Further Gains?Zacks Investment Research • 03/30/23
Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter NarcanInvestorPlace • 03/29/23
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions' NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency TreatmentGlobeNewsWire • 03/29/23
FDA approves over-the-counter sales of lifesaving opioid overdose treatment Narcan nasal sprayCNBC • 03/29/23
Wall Street Analysts Believe Emergent Biosolutions (EBS) Could Rally 134.29%: Here's is How to TradeZacks Investment Research • 02/28/23
Analysts Estimate Emergent Biosolutions (EBS) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/20/23
Emergent BioSolutions: Positive NARCAN FDA Panel, Divesting Travel Health, Raising Rating To BuySeeking Alpha • 02/19/23
Emergent's stock jumps after FDA panel favors over-the-counter sales of NarcanMarket Watch • 02/16/23
Emergent Biosolutions (EBS) Moves 12.5% Higher: Will This Strength Last?Zacks Investment Research • 02/16/23
Emergent BioSolutions Reports FDA Advisory Committees' Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter UseGlobeNewsWire • 02/15/23
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 MillionGlobeNewsWire • 02/15/23
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutionsGlobeNewsWire • 02/15/23
Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023GlobeNewsWire • 02/06/23
Emergent (EBS) to Start Restructuring Plan, Lays Off 5% WorkforceZacks Investment Research • 01/10/23
Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of DefenseGlobeNewsWire • 01/05/23